Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/13 → 12/31/16 |
Funding
- PRA Health Sciences (GS-US-337-0108 // GS-US-337-0108)
- Gilead Sciences, Inc (GS-US-337-0108 // GS-US-337-0108)
Prot #GS-US-337-0108: A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin for 8 Weeks and Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Trea
- Flamm, Steven L (PD/PI)
Project: Research project